Algert Global’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Algert Global's ATRC Position: Q2 2026 in Review
Algert Global reduced its AtriCure (ATRC) stake by 65% in Q2 2026, selling an estimated $747K and leaving 14,239 shares worth $398K. The position accounts for ﹤0.01% of the portfolio, ranked #1103.
Algert Global first reported a position in ATRC in Q2 2022 and has held it in 16 quarters since. The position peaked at $10.3M in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Algert Global held 14,239 shares of AtriCure worth $398K as of Q2 2026.
- Algert Global sold 26,560 AtriCure shares in Q2 2026, an estimated $747K.
- AtriCure made up ﹤0.01% of Algert Global's portfolio in Q2 2026, its #1103 holding.
- Algert Global first reported a position in AtriCure in Q2 2022 and has held it in 16 quarters since.
- Algert Global's AtriCure position peaked at $10.3M in Q4 2025.
- 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.